Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 3/20 | 0.53 |
| ▸ | IDH1 | O75874 | 1/20 | 0.44 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 2/20 | 0.42 |
| ▸ | CCR1 | P32246 | 2/20 | 0.41 |
| ▸ | CCR8 | P51685 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALPL | P05186 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | ALPI | P09923 | 1/20 | 0.41 |
| ▸ | ALPG | P10696 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CCR5 | P51681 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9220648 | 0.97 | CTSS (0.55) | CTSSIDH1SOS2NPY5RCTSK | |
| SCHEMBL29988787 | 0.97 | CTSS (0.55) | CTSSIDH1SOS2NPY5RCTSK | |
| SCHEMBL8406858 | 0.86 | IDH1 (0.53) | CTSSIDH1SOS2NPY5RCTSK | |
| SCHEMBL19194999 | 0.85 | CTSS (0.50) | CTSSIDH1SOS2NPY5RCTSK | |
| SCHEMBL995983 | 0.84 | SOS2 (0.50) | CTSSIDH1SOS2NPY5RCTSK | |
| SCHEMBL994386 | 0.83 | KDM4E (0.63) | CTSSCCR1CCR8KDM4ELMNA | |
| SCHEMBL317148 | 0.82 | KMT2A (0.60) | CTSSCTSKKDM4ELMNAMAPK1 | |
| SCHEMBL14007665 | 0.82 | CTSS (0.51) | CTSSCTSKKDM4ELMNASMN1; SMN2 | |
| SCHEMBL18423239 | 0.80 | CTSS (0.43) | CTSSIDH1SOS2NPY5RCTSK | |
| SCHEMBL12598663 | 0.79 | CTSS (0.46) | CTSSCTSKKDM4ELMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025084975-A1 | A BI-PHASIC ELECTROLYSIS CELL FOR CARBON DIOXIDE CAPTURE, ELECTROCATALYSTS FOR USE IN THE CELL, RELATED METHODS AND A PRODUCTION FACILITY USING THE ELECTROLYSIS CELL AND THE ELECTROCATALYSTS | CarbGen AB (SE) | 2025-04-24 | — | — | WO | disclosed |
| EP-2188620-B1 | COMPOUNDS USEFUL AS LIGANDS AND PARTICULARLY AS ORGANIC CHROMOPHORES FOR COMPLEXING LANTHANIDES AND APPLICATIONS THEREOF | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-08-23 | — | — | EP | disclosed |
| EP-2188620-B1 | COMPOUNDS USEFUL AS LIGANDS AND PARTICULARLY AS ORGANIC CHROMOPHORES FOR COMPLEXING LANTHANIDES AND APPLICATIONS THEREOF | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-08-23 | — | — | EP | disclosed |
| US-9040689-B2 | Compounds useful as ligands and particularly as organic chromophores for complexing lanthanides and applications thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2015-05-26 | — | — | US | disclosed |
| US-9040689-B2 | Compounds useful as ligands and particularly as organic chromophores for complexing lanthanides and applications thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2015-05-26 | — | — | US | disclosed |
| US-9040689-B2 | Compounds useful as ligands and particularly as organic chromophores for complexing lanthanides and applications thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2015-05-26 | — | — | US | disclosed |
| US-8709129-B2 | Compounds useful as ligands of actinides, their synthesis and their uses | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2014-04-29 | — | — | US | disclosed |
| EP-2456766-B1 | COMPOUNDS SUITABLE FOR USE AS ACTINIDE LIGANDS, SYNTHESIS AND USES THEREOF | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2013-11-06 | — | — | EP | disclosed |
| EP-2456766-B1 | COMPOUNDS SUITABLE FOR USE AS ACTINIDE LIGANDS, SYNTHESIS AND USES THEREOF | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2013-11-06 | — | — | EP | disclosed |
| US-20120186396-A1 | COMPOUNDS USEFUL AS LIGANDS OF ACTINIDES, THEIR SYNTHESIS AND THEIR USES | UNIVERSITE DE NANTES (FR) | 2012-07-26 | — | — | US | disclosed |
| EP-2188620-A1 | COMPOUNDS USEFUL AS LIGANDS AND PARTICULARLY AS ORGANIC CHROMOPHORES FOR COMPLEXING LANTHANIDES AND APPLICATIONS THEREOF | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2010-05-26 | — | — | EP | disclosed |
| WO-2009037277-A1 | COMPOUNDS USEFUL AS LIGANDS AND PARTICULARLY AS ORGANIC CHROMOPHORES FOR COMPLEXING LANTHANIDES AND APPLICATIONS THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2009-03-26 | — | — | WO | disclosed |
| WO-2009037277-A1 | COMPOUNDS USEFUL AS LIGANDS AND PARTICULARLY AS ORGANIC CHROMOPHORES FOR COMPLEXING LANTHANIDES AND APPLICATIONS THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2009-03-26 | — | — | WO | disclosed |
| EP-0403593-B1 | TERPYRIDINE DERIVATIVES | WALLAC OY (FI) | 1997-03-19 | — | — | EP | disclosed |
| US-5539117-A | 2-acetyl-6-cyanopyridines and their use as intermediates in the synthesis of oligo-2,6-pyridines | GE HEALTHCARE AS (NO) | 1996-07-23 | — | — | US | disclosed |
| US-5457186-A | Immunoassay | WALLAC OY (FI) | 1995-10-10 | — | — | US | disclosed |
| EP-0649020-A1 | Luminescent lanthanide chelates with decreased non-radiative energy loss | WALLAC OY (FI) | 1995-04-19 | — | — | EP | disclosed |
| US-5350696-A | 2-acetyl-6-cyanopyridines and their use as intermediates in the synthesis of oligo-2,6-pyridines | STERLING WINTHROP, INC. (US) | 1994-09-27 | — | — | US | disclosed |
| US-5324825-A | Terpyridine derivatives | WALLAC OY (FI) | 1994-06-28 | — | — | US | disclosed |
| US-5202423-A | Terpyridine derivatives | WALLAC OY | 1993-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120186396-A1 | COMPOUNDS USEFUL AS LIGANDS OF ACTINIDES, THEIR SYNTHESIS AND THEIR USES | AHR, ARNT, HRH3 | CTSS 1760/4885IDH1 1367/4885SOS2 3164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.